IMMUNIC, INC. Logo

IMMUNIC, INC.

Develops oral small molecule therapies for chronic inflammatory and autoimmune diseases.

IMUX | US

Overview

Corporate Details

ISIN(s):
US4525EP1011 (+1 more)
LEI:
549300R5T12FW5MEQB20
Country:
United States of America
Address:
1200 AVENUE OF THE AMERICAS, 10036 NEW YORK

Description

Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's mission is to create high-quality, oral treatment options that offer comprehensive therapeutic efficacy with favorable safety and tolerability profiles. Its clinical development programs target conditions with significant unmet medical needs, including multiple sclerosis and celiac disease, aiming to provide patients with convenient and effective solutions to manage debilitating symptoms and improve their quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-05-15 18:08
10-Q
English ZIP 9.6 MB
2025-05-15 16:07 English ZIP 11.3 KB
2025-05-15 10:00 English ZIP 9.8 KB
2025-04-30 09:37 English ZIP 11.6 MB
2025-04-22 19:15 English ZIP 349.9 KB
2025-04-22 19:15 English ZIP 405.9 KB
2025-04-09 19:27 English ZIP 336.2 KB
2025-04-09 19:26 English ZIP 364.3 KB
2025-03-31 11:09
10-K
English ZIP 21.2 MB
2025-02-20 08:30 English ZIP 4.4 MB
2025-02-14 11:16 English ZIP 11.5 KB
2025-02-12 10:44 English ZIP 10.1 KB
2025-01-30 22:57 English ZIP 8.3 KB
2025-01-13 09:32 English ZIP 21.1 MB
2024-12-18 17:36 English ZIP 1.2 MB

Automate Your Workflow. Get a real-time feed of all IMMUNIC, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUNIC, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUNIC, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.